PREGABALIN LAPL pregabalin 225 mg capsule blister pack

País: Austràlia

Idioma: anglès

Font: Department of Health (Therapeutic Goods Administration)

ingredients actius:

pregabalin, Quantity: 225 mg

Disponible des:

Lupin Australia Pty Limited

Designació comuna internacional (DCI):

Pregabalin

formulario farmacéutico:

Capsule, hard

Composición:

Excipient Ingredients: pregelatinised maize starch; purified talc; propylene glycol; ethanol; butan-1-ol; isopropyl alcohol; purified water; Shellac; strong ammonia solution; iron oxide black; potassium hydroxide; titanium dioxide; iron oxide red; Gelatin; sodium lauryl sulfate; ethanol absolute

Vía de administración:

Oral

Unidades en paquete:

60, 20, 14, 56

tipo de receta:

(S4) Prescription Only Medicine

indicaciones terapéuticas:

Pregabalin LAPL is indicated for the treatment of neuropathic pain in adults. Pregabalin LAPL is indicated as adjunctive therapy in adults with partial seizures with or without secondary generalisation.

Resumen del producto:

Visual Identification: Size '1' capsules with light brown cap and white body, imprinted with "PG" on cap and "225" on body in black ink, containing white to off white powder; Container Type: Blister Pack; Container Material: PVC/Al; Container Life Time: 24 Months; Container Temperature: Store below 25 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert

Estat d'Autorització:

Licence status A

Data d'autorització:

2014-12-05